Ketoanalogue Supplementation in CKD Stages 3‑5: Evidence‑Based Recommendations

Guideline Recommendations

The 2020 KDOQI (Kidney Disease Outcomes Quality Initiative) guidelines recommend protein restriction with or without ketoanalogues to reduce the risk of end‑stage kidney disease (ESKD) or death (Grade 1A evidence) and to improve quality of life (Grade 2C evidence in metabolically stable adults with CKD 3‑5)【1】.
The 2024 KDIGO (Kidney Disease: Improving Global Outcomes) guidelines advise that patients at risk of kidney failure who are willing and able may be considered for a very low‑protein diet (0.3‑0.4 g/kg/day) supplemented with essential amino acids or ketoacid analogs (up to 0.6 g/kg/day), provided they are under close supervision【6】.

Low‑protein diet alone: 0.55‑0.60 g protein/kg body weight per day【1】.
Very low‑protein diet with ketoanalogues: 0.28‑0.43 g dietary protein/kg body weight per day plus ketoanalogue supplementation to reach a total protein equivalent of 0.55‑0.60 g/kg/day【1】.

Appropriate candidates: Metabolically stable adults with CKD stages 3‑5 who are at heightened risk of kidney failure【1】【6】.
Contraindicated or cautionary groups: Metabolically unstable patients, children (risk of growth impairment), and frail older adults with sarcopenia who may require higher protein intake【6】.

Prescribe a very low‑protein diet (0.28‑0.43 g/kg/day) together with ketoanalogue supplementation so that the total protein intake equals 0.55‑0.60 g/kg/day【1】.

Close clinical supervision is mandatory for all patients on this regimen【1】.
Regular assessments should include:
- Appetite and dietary intake【1】
- Body‑weight trends【1】
- Biochemical markers: serum albumin, prealbumin, electrolytes, phosphorus, calcium, and parathyroid hormone (PTH)【1】
- Anthropometric measurements (e.g., mid‑arm circumference, lean body mass)【1】

A registered dietitian nutritionist must deliver medical nutrition therapy in close collaboration with the treating physician to ensure nutritional adequacy and to minimize disease progression【1】.

For adults with diabetes and CKD 3‑5, the KDOQI guidelines recommend a less restrictive protein intake of 0.6‑0.8 g/kg/day to preserve nutritional status and support glycemic control; ketoanalogue supplementation is optional and not strongly endorsed【1】.